Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Molecular Metabolism
|
September 30, 2023
Sympathetic overdrive and unrestrained adipose lipolysis drive alcohol-induced hepatic steatosis in rodents
Chunxue Zhou, Henry H Ruiz, Li Ling, et al.
Journal of the American Geriatrics Society
|
May 24, 2023
High-intensity home health physical therapy among older adult Veterans: A randomized controlled trial
Jennifer E Stevens-Lapsley, Danielle Derlein, Laura Churchill, et al.
European Journal of Pharmacology
|
January 27, 2009
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists
Julia N Heinrich, John A Butera, Tikva Carrick, et al.
Frontiers in Human Neuroscience
|
July 19, 2019
Interpreting Prefrontal Recruitment During Walking After Stroke: Influence of Individual Differences in Mobility and Cognitive Function
Sudeshna A Chatterjee, Emily J Fox, Janis J Daly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 21, 1999
Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat
A Wojdan, C Freeden, M Woods, et al.
Cell Metabolism
|
October 22, 2024
Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity
Kenichi Sakamoto, Mary A Butera, Chunxue Zhou, et al.
Clinical Rehabilitation
|
March 16, 2021
Rehabilitation with accurate adaptability walking tasks or steady state walking: A randomized clinical trial in adults post-stroke
David J Clark, Dorian K Rose, Katie A Butera, et al.
Journal of Medicinal Chemistry
|
January 30, 2009
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation
John A Butera, Bjarne Due Larsen, James K Hennan, et al.
Journal of Medicinal Chemistry
|
March 29, 2000
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity
J A Butera, M M Antane, S A Antane, et al.
Journal of Medicinal Chemistry
|
January 17, 2009
Prodrugs of perzinfotel with improved oral bioavailability
Reinhardt B Baudy, John A Butera, Magid A Abou-Gharbia, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Molecular Metabolism
|
September 30, 2023
Sympathetic overdrive and unrestrained adipose lipolysis drive alcohol-induced hepatic steatosis in rodents
Chunxue Zhou, Henry H Ruiz, Li Ling, et al.
Journal of the American Geriatrics Society
|
May 24, 2023
High-intensity home health physical therapy among older adult Veterans: A randomized controlled trial
Jennifer E Stevens-Lapsley, Danielle Derlein, Laura Churchill, et al.
European Journal of Pharmacology
|
January 27, 2009
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists
Julia N Heinrich, John A Butera, Tikva Carrick, et al.
Frontiers in Human Neuroscience
|
July 19, 2019
Interpreting Prefrontal Recruitment During Walking After Stroke: Influence of Individual Differences in Mobility and Cognitive Function
Sudeshna A Chatterjee, Emily J Fox, Janis J Daly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 21, 1999
Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat
A Wojdan, C Freeden, M Woods, et al.
Cell Metabolism
|
October 22, 2024
Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity
Kenichi Sakamoto, Mary A Butera, Chunxue Zhou, et al.
Clinical Rehabilitation
|
March 16, 2021
Rehabilitation with accurate adaptability walking tasks or steady state walking: A randomized clinical trial in adults post-stroke
David J Clark, Dorian K Rose, Katie A Butera, et al.
Journal of Medicinal Chemistry
|
January 30, 2009
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation
John A Butera, Bjarne Due Larsen, James K Hennan, et al.
Journal of Medicinal Chemistry
|
March 29, 2000
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity
J A Butera, M M Antane, S A Antane, et al.
Journal of Medicinal Chemistry
|
January 17, 2009
Prodrugs of perzinfotel with improved oral bioavailability
Reinhardt B Baudy, John A Butera, Magid A Abou-Gharbia, et al.
Page
of 7